Concepedia

Karen Oldman

KO

Statistics

Publications

7

Citations

208

H-Index

7

Active since

2009

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (United States)

Karen Oldman is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacology, and cardiovascular pharmacology.

Publications per year

2009–2016

7

Publications

7

A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions

Lorna Ewart, Aileen Milne, Debbie Adkins et al. · Journal of Pharmacological and Toxicological Methods · 2013 · 52 citations

, , +11

Enhanced Characterization of Contractility in Cardiomyocytes During Early Drug Safety Assessment

Larissa Butler, Caroline Cros, Karen Oldman et al. · Toxicological Sciences · 2015 · 41 citations · Full text

, , +15

Assessment of extracellular field potential and Ca2+ transient signals for early QT/pro-arrhythmia detection using human induced pluripotent stem cell-derived cardiomyocytes

Najah Abi‐Gerges, Amy Pointon, Karen Oldman et al. · Journal of Pharmacological and Toxicological Methods · 2016 · 33 citations

, , +16

Preservation of cardiomyocytes from the adult heart

Najah Abi‐Gerges, Amy Pointon, Georgia F. Pullen et al. · Journal of Molecular and Cellular Cardiology · 2013 · 27 citations

, , +12

The rat bone marrow micronucleus test--study design and statistical power

Julie E. Hayes, Ann Doherty, D. J. Adkins et al. · Mutagenesis · 2009 · 26 citations

, , +14

1–5 of 7